Skip to main content
SpringerLink
Log in

Asthma drug pricing a problem for many countries

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. from the International Union Against Tuberculosis and Lung Disease and the University of Auckland School of Population Health

References

  1. Babar Z-U-D, et al. The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries. PharmacoEconomics : 15 Oct 2013. Available from: URL: http://dx.doi.org/10.1007/s40273-013-0095-9

  2. Rosenthal E. The Soaring Cost of a Simple Breath. New York Times : 12 Oct 2013. Available from: URL: http://www.nytimes.com

  3. Fuseworks Ltd. Asthma medicines a struggle for many countries - study. Media Release : 15 Oct 2013. Available from: URL: http://nz.news.yahoo.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asthma drug pricing a problem for many countries. PharmacoEcon Outcomes News 690, 4 (2013). https://doi.org/10.1007/s40274-013-0818-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0818-3

Search

Navigation